Your session is about to expire
← Back to Search
Educational Materials for Deprescribing in Multiple Chronic Conditions
N/A
Waitlist Available
Led By Ariel Green, MD, MPH, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial will study whether a deprescribing intervention is feasible and acceptable for patients with mild cognitive impairment or dementia and/or multiple chronic conditions, their care partners, and clinicians.
Who is the study for?
This trial is for adults aged 65+ with mild cognitive impairment or dementia, plus another chronic condition and taking five or more medications. It's also for those aged 75+ without dementia but with multiple chronic conditions on similar medication regimens. Participants must have a primary care physician in the study clinic and be able to hear well enough for phone interviews.Check my eligibility
What is being tested?
The study tests an educational intervention aimed at deprescribing (safely reducing medications) in patients with cognitive issues or multiple health problems. It includes education materials for patients/caregivers and training sessions for clinicians to raise awareness about deprescribing processes.See study design
What are the potential side effects?
Since this trial focuses on educational materials rather than medical treatments, there are no direct side effects from drugs being tested. However, changes in medication regimens as a result of the intervention could potentially lead to side effects which will be monitored.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability of the intervention to be assessed qualitatively from debriefing interviews
Feasibility of the intervention to be assessed qualitatively from debriefing interviews
Secondary outcome measures
Preliminary efficacy to be assessed from primary care clinician's clinical notes
Trial Design
1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
The intervention consists of providing educational materials on deprescribing to:
Patient and care partner cohort
Primary care physician cohort
Find a Location
Who is running the clinical trial?
Johns Hopkins UniversityLead Sponsor
2,260 Previous Clinical Trials
14,820,759 Total Patients Enrolled
Reading Hospital Family Health Care CenterUNKNOWN
National Institute on Aging (NIA)NIH
1,671 Previous Clinical Trials
28,017,042 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a regular check-up scheduled with my doctor during the study.I am 65 or older with MCI/dementia, take 5+ meds, have a chronic condition, and can hear well for phone interviews.I am 75 or older, without dementia, have 2+ chronic conditions, take 5+ medications, and can hear well for phone interviews.I take more than 4 different medications for my health.I am over 21 and can participate in phone interviews.You have a primary care physician at the pilot clinic who has enrolled in the study.The study has two groups: one for people with mild memory problems or dementia, and one for those without dementia.I have been diagnosed with MCI or dementia.You have at least one other long-term health condition.I am 75 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants have been admitted to the trial thus far?
"Affirmative. According to clinicaltrials.gov, the trial announced on May 19th 2022 is still recruiting participants. The details of this study were last modified on the 26th of May and it requires 50 persons from one research centre."
Answered by AI
Are applicants currently being accepted for this experiment?
"Affirmative. Clinicaltrials.gov holds data that verifies this study, which was published on May 19th 2022 and updated recently as of May 26th 2022, is actively searching for 50 candidates from a single medical facility."
Answered by AI
Who else is applying?
What state do they live in?
Pennsylvania
What site did they apply to?
Reading Hospital Family Health Care Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger